Initial clinical tests show that biosensors could pave the way for a personalized antibiotherapy in the future
Personalized drug therapy, adjusting the dose, dosage intervals, and the duration of treatment to fit individual patients’ needs, are getting more and more important. Frequently, medications are dosed in such a way that each patient receives the same standardized amount of a certain drug. Thereby, clinical conditions of the patient, such as state of health, metabolism, or other physical factors, are often not sufficiently considered. A researcher team at the University of Freiburg has developed a bioanalytical method which can measure the class of ?-lactam antibiotics in human blood on-site – in the operating room, intensive ward or doctor’s office, as well as on a house call. “This way, we can easily determine just how quickly the human body metabolizes a drug,” said the microsystems engineer Dr. Can Dincer, who is the head of the research team. The researchers recently published their results in the journal “Scientific Reports”.
This new method makes it possible to individually adjust the necessary dose of a medication for each patient. “We’ve proven the applicability of our system for a personalized antibiotherapy by on-site monitoring the clearance of drugs in two patients, who were treated with ß-lactam antibiotics, undergoing surgery” Dincer said. “Based on these results, our next step will be to perform a quantitative cohort study that will determine the usefulness of personalized antibiotherapy.”, he added.
Already at the end of 2016, the research team presented its biosensor technology that allows the rapid and simultaneous monitoring of different antibiotics in human blood (www.pr.uni-freiburg.de/pm/2016/pm.2016-11-14.159). In their recently published study, the scientists further developed their system by implementing another natural sensor protein that can quantify ?-lactam antibiotics. In human medicine, ?-lactam antibiotics are often used to prevent and treat infectious diseases.
Learn more: Personalize your medication dosages
The Latest on: Personalized medicine
- AI in veterinary medicine: From finding disease to predicting iton November 24, 2020 at 11:43 am
In an abstract presented at American College of Veterinary Internal Medicine (ACVIM) Forum in June 2019 ... tangible way to inspire pet-owner compliance with a highly personalized care plan designed ...
- Comcast, IBC joint venture Quil inks deals with Penn Medicine and AmeriHealth Caritason November 24, 2020 at 7:53 am
IBC joint venture Quil inks separate deals with the Philadelphia area's largest health system and the region's largest Medicaid managed care company.
- New nanotechology design provides hope for personalized ‘vaccination’ to treat canceron November 23, 2020 at 11:03 am
Published in Science Advances, a new study by University of Chicago scientists demonstrates a new approach that delivers a one-two punch against cancer cells: using tiny metal-organic frameworks to ...
- Ted Snelgrove Joins Personalized Medicine Foundation Board of Directorson November 23, 2020 at 9:08 am
The Personalized Medicine Foundation (PMF) a leading cancer patient advocacy organization focused on patient education ...
- Precision Medicine Market Sets 2025 Economic Growth Target with Higher Percent, a Post-COVID 19 Planon November 23, 2020 at 7:03 am
Precision Medicine Market Insight According to the 2020 Market Research Future Survey, the analysts saw 12.48% of ...
- Estonian social affairs minister establishes personalized medicine councilon November 23, 2020 at 4:27 am
Minister of Social Affairs Tanel Kiik (Center) on Friday formed the personalized medicine council, the aim of which is to compile a comprehensive long-term program for the development of personalized ...
- Precision Medicine Group Secures Major Investment from Blackstoneon November 20, 2020 at 6:01 am
Precision Medicine Group (PMG) and Blackstone (NYSE: BX) today announced that PMG, a leading next-generation provider of drug development and commercialization services, has completed a major ...
- Tech Talk: Personalized cancer vaccines, virtual STEM, and biotech startupson November 20, 2020 at 12:00 am
With a major research university right in our backyard, a strong military presence and innovative companies spread throughout the metro region, there’s often a plethora of interesting science and tech ...
- Dr. Greene on the Future of Personalized Therapy in Prostate Canceron November 19, 2020 at 11:02 pm
Greene, MD, MAS, FACS, discusses the future of personalized therapy in prostate cancer. Kirsten L. Greene, MD, MAS, FACS, associate chief medical officer, Paul Mellon Professor and Chair, UVA ...
- Digital Health Tools Offer New Opportunities for Personalized Careon November 18, 2020 at 6:06 am
Digital health has rapidly become a core component of the delivery of health care in the United States. Health systems have implemented new technology platforms to allow for more virtual visits.
via Google News and Bing medicine